Related Experiment Video
Updated: Mar 31, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography
Won-Woo Seo1, Hack-Lyoung Kim2, Yong-Jin Kim3
1Division of Cardiology, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea; Hallym University College of Medicine, Seoul, Republic of Korea.
Insights
Combining high-sensitivity C-reactive protein (hs-CRP) testing with coronary computed tomography angiography (CCTA) significantly improves cardiovascular event prediction in patients with suspected coronary artery disease (CAD). This combined approach enhances risk stratification for better treatment strategies.
Area of Science:
- Cardiology
- Medical Imaging
- Biomarkers
Background:
- Cardiovascular disease (CAD) remains a leading cause of mortality worldwide.
- Accurate risk stratification is crucial for effective management of patients with suspected CAD.
- Coronary computed tomography angiography (CCTA) is a key imaging modality for diagnosing CAD.
Purpose of the Study:
- To evaluate the added prognostic value of high-sensitivity C-reactive protein (hs-CRP) levels combined with CCTA results.
- To determine if this combination improves cardiovascular event prediction in patients with suspected CAD.
- To assess the utility of hs-CRP for risk stratification in patients undergoing CCTA.
Main Methods:
- A cohort of 445 patients with suspected CAD underwent both CCTA and hs-CRP measurement.
- Cardiovascular events (cardiac death, myocardial infarction, unstable angina, late revascularization) were tracked.
- Statistical analyses, including Kaplan-Meier and chi-square tests, were used to assess prognostic value.
Main Results:
- Obstructive CAD (stenosis ≥50%) and high hs-CRP (≥2.25mg/L) were independent predictors of cardiovascular events.
- The combination of hs-CRP and CCTA significantly increased predictive power (global chi-square ratio from 13.51 to 19.14, p=0.022).
- Patients with both obstructive CAD and high hs-CRP had a 21.0-fold higher event risk compared to low-risk individuals (p=0.007).
Conclusions:
- The combined use of hs-CRP levels and CCTA results significantly enhances prognostic power for cardiovascular events in patients with suspected CAD.
- hs-CRP measurement offers a simple and valuable tool for risk stratification and guiding treatment strategies in patients undergoing CCTA.
- This integrated approach aids in identifying high-risk individuals requiring more intensive management.
Background:
This study was performed to investigate whether combined use of high-sensitivity C-reactive protein (hs-CRP) levels and coronary computed tomography angiography (CCTA) results have additional prognostic value for predicting cardiovascular events in patients with suspected coronary artery disease (CAD).
Methods:
A total of 445 patients (61.6±9.3 years and 62.9% men) with suspected CAD who underwent both CCTA and hs-CRP measurement within one month were evaluated. Information on cardiovascular events, including cardiac death, non-fatal myocardial infarction, unstable angina and late (≥six months after CCTA) coronary revascularization was assessed.
Results:
One hundred and eighty-five patients (41.6%) had obstructive CAD on CCTA (stenosis ≥50%). Both high hs-CRP (≥2.25mg/L) and obstructive CAD were the independent predictors of cardiovascular events. Kaplan-Meier analysis showed that event rates were significantly different according to the presence of obstructive CAD and hs-CRP levels. Addition of hs-CRP levels to combined information of clinical factors and CCTA results further increased the predictive power for cardiovascular events (global chi-square ratio, from 13.51 to 19.14, p=0.022). Event risks were approximately 21.0-fold higher in the highest-risk group with both obstructive CAD and high hs-CRP levels than in the lowest-risk group with both insignificant CAD and low hs-CRP levels (p=0.007).
Conclusions:
Combined use of hs-CRP levels and CCTA results provided a significant improvement in prognostic power for cardiovascular events in patients with suspected CAD. hs-CRP measurement may be a simple and useful method for determining risk stratification and treatment strategy in patients undergoing CCTA.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview

